伊索拉定

伊索拉定
	IUPAC名; 6-(2,5-Dichlorophenyl)1,3,5-triazine-2,4-diamine
別名	DCPDAT, Dicloguamine, MN-1695.
識別
CAS號	57381-26-7
PubChem	3752
ChemSpider	3621
性質
化學式	C9H7Cl2N5
摩爾質量	256.09 g·mol−1
藥理學
ATC代碼	A02BX16（A02）
	若非註明，所有數據均出自標準狀態（25 ℃，100 kPa）下。

伊索拉定（英語：Irsogladine，化學名：6-(2,5-二氯苯基)1,3,5-三嗪-2,4-二胺，6-(2,5-Dichlorophenyl)1,3,5-triazine-2,4-diamine，縮寫DCPDAT）是一種含氮有機氯化合物，化學式C₉H₇Cl₂N₅，可用作磷酸二酯酶抑制藥^[1]。

參考文獻

^ Satoh, H; Amagase, K; Takeuchi, K. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats. The Journal of Pharmacology and Experimental Therapeutics. 2013, 348 (2): 227–35. PMID 24254524. S2CID 23740642. doi:10.1124/jpet.113.208991.
^ Serradell, MN; Blancafort, P.; Castaer, J.; MN-1695. Drugs Fut 1983, 8, 6, 502.
^ Ueda F, Aratani S, Mimura K, Kimura K, Nomura A, Enomoto H. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals. Arzneimittelforschung. 1984;34(4):474-7. PMID 654016.
^ DE2506814 idem Hiromu Murai, 6 More », 美國專利第3,966,728號 (1976 to Nippon Shinyaku Co., Ltd.).
^ ChemDrug

[1] Satoh, H; Amagase, K; Takeuchi, K. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats. The Journal of Pharmacology and Experimental Therapeutics. 2013, 348 (2): 227–35. PMID 24254524. S2CID 23740642. doi:10.1124/jpet.113.208991.

[2] Serradell, MN; Blancafort, P.; Castaer, J.; MN-1695. Drugs Fut 1983, 8, 6, 502.

[3] Ueda F, Aratani S, Mimura K, Kimura K, Nomura A, Enomoto H. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals. Arzneimittelforschung. 1984;34(4):474-7. PMID 654016.

[4] DE2506814 idem Hiromu Murai, 6 More », 美國專利第3,966,728號 (1976 to Nippon Shinyaku Co., Ltd.).

[5] ChemDrug

[1]

[2]

[3]

[4]

[5]